3.7 PFAS MDL Update

Despite several big and small settlements in advance of the first planned AFFF MDL bellwether trial in June, the overwhelming majority of actions in the MDL remain unresolved. This panel will discuss the scope of the proposed settlements to date, what issues remain, and the ramifications for the parties in the MDL as well as inother current or potential litigation. This will include an overview of some of the central technical and legal arguments as well as the limitations of the current state of the science as it applies to the execution of forensic evaluations, treatment options, and the toxicological risk assessment.